Author:
Stuart Kirsty E.,Houssami Nehmat,Taylor Richard,Hayen Andrew,Boyages John
Funder
Westmead Breast Cancer Institute, which in turn is funded by the NSW Government - Department of Health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference60 articles.
1. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2004;96:6.
2. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer. 1999;85:3.
3. Early Breast Cancer Trialists’ Collaborative G, Correa C, McGale P, Taylor C, Wang Y, Clarke M, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162–77. doi: 10.1093/jncimonographs/lgq039 .
4. Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev. 2009;1:CD000563.
5. Petrelli F, Barni S. Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials. Radiother Oncol. 2011;100:2.
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献